skip to content

An Interdisciplinary Research Centre at the University of Cambridge
 
Read more at: Dr Ana C. da Silva

Dr Ana C. da Silva

What I do:

Currently, I'm investigating the role of uncultured bacteria in the human gut, with the goal of understanding how the composition of the gut microbiome may influence the incidence of gut-related human diseases.


Read more at: Dr Lu Yang

Dr Lu Yang

What I do:

I’m a postdoctoral fellow at Beijing Center for Disease Prevention and Control and College of Veterinary Medicine, China Agricultural University. And now a visiting scholar in the Pathogen Genomics and Evolution Group of the University of Cambridge.




Read more at: Dr Qi Yin

Dr Qi Yin

What I do:

I study meta-genomics analysis of the human gut microbiome and the development of potential antibacterial agents derived from gut microbes.


Read more at: Kristina Kordova

Kristina Kordova

What I do:

Applying machine learning for the discovery of novel antimicrobial resistance variants in Klebsiella pneumoniae.


Research Interests:

  • Antimicrobial resistance
  • Bacterial genomics
  • Machine learning
  • Single-cell sequencing

Read more at: Lauren Adams

Lauren Adams

Research focus:

  • Epidemiology and mathematical modelling to support the infant immunisation schedule in England and Wales.
  • Estimating the number of cases prevented by introducing a MenACWY vaccination dose into the UK infant schedule. - Funded by the HPRU for immunisation and presented to the JCVI.

Read more at: Dr Kate Hughes

Dr Kate Hughes

What I do:

I am a research-active veterinary pathologist focussing on mammary gland biology and pathology. As such I am interested in mastitis and the mammary gland's response to mastitis pathogens. A secondary interest lies in the field of lagomorph pathology including host response to hepatic parasites.


Read more at: Mark Owusu

Mark Owusu

I am interested in using mathematical models to inform decisions on vaccination policies on meningitis in the African meningitis belt. Currently, my work focuses on figuring the key age group(s) to be targeted on the pentavalent vaccines due to be licenced by the end of 2022 in the African meningitis belt in order to maximize health benefits at a minimum cost.


Read more at: Dr Alexandre Almeida

Dr Alexandre Almeida

About my research:

My research group combines large-scale computational and experimental approaches to understand the biological role of uncultured, gut-associated bacteria, and to explore their antimicrobial potential.
Our main areas of focus are: